All brain imaging procedures that ALZ-NET participants undergo should be conducted per local practice, applicable procedure standards, appropriate use guidelines, and applicable FDA labels of Alzheimer’s disease therapies. This page provides guidance and recommendations for the brain imaging services that should be provided to ALZ-NET participants. Resources include recommend training, acquisition protocols, scanner information, required sequences, and reporting guidelines and templates for Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI).
Note: Instructions on how to transfer imaging data to the ALZ-NET operations center, The American College of Radiology, can be found on the Image Submission Page of the ALZ-NET website.
General PET Resources
Amyloid PET Resources
Tau PET Resources
FDA labels for Tau PET radiotracers:
Amyloid Related Imaging Abnormalities (ARIA) Management
Amyloid-Related Imaging Abnormalities with Emerging Alzheimer Disease Therapeutics: Detection and Reporting Recommendations for Clinical Practice (article) - American Journal of Neuroradiology, September 2022